Virtual Reality: Distraction During Small Bore Intercostal Chest Drain Insertion

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorNational University of Malaysia

About this trial

Intercostal chest drain (ICC) insertion is a common procedure done worldwide to treat and diagnose pleural disease. It is used to evacuate fluid, blood, or air in the cavity from a myriad of causes namely pleural effusions of different etiologies, empyema, hemothorax, chylothorax and pneumothorax. It also functions as a route for antibiotics, pleurodesis and fibrinolytics. Hippocrates, whose practiced medicine 2,400 years ago, is often credited with being the first to insert a metal tube into the pleural region to drain fluid. It wasn't until the 19th century that a closed drainage system was properly documented in the literature, although open drainage remained to be the norm for quite some time.

In the past, large-bore tubes (24-32 F) were recommended in nearly all circumstances and were inserted using a blunt dissection technique. However, during the past two decades, small-bore catheters have become increasingly popular. They were first used to drain abdominal collections and have now been adopted for use in draining the pleural cavity utilizing the needle and guide wire Seldinger procedure, typically with radiological guidance. In addition to that, Seldinger technique allow us to insert the catheter at lower intercostals spaces without injury to the diaphragm or abdominal organs, thereby ensuring patient safety.

Eligibility criteria

Qualifiers

All participants undergoing ICC insertion

Participants who could understand and give consent

Disqualifiers

Participants who are unable to understand or give consent

Ventilated patients

Participants who are not comfortable wearing VR device

Participants who are unable to communicate (illiterate, had hearing impairment, mute, blind or had memory impairment)

Trial design

Treatments tested in this trial

  • Virtual Reality Device
  • Without virtual reality

Treatment groups

80 Participants
are divided into 2 treatment groups